SOLIGENIX, INC. Increase (Decrease) in Accounts Payable, Trade
SOLIGENIX, INC. (SNGX) reported Increase (Decrease) in Accounts Payable, Trade of $188.04 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2016-08-11
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for the quarter ending 2016-06-30 was -$64.80K, a 170.05% decline year-over-year.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for the quarter ending 2016-03-31 was $252.84K.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for the quarter ending 2015-12-31 was $32.52K.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for the quarter ending 2015-09-30 was $1.71M, a 56.44% increase year-over-year.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for fiscal 2015 was $1.38M, a 7.20% decline from fiscal 2014.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for fiscal 2014 was $1.48M, a 274.76% increase from fiscal 2013.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for fiscal 2013 was $395.79K.
- SOLIGENIX, INC. increase (decrease) in accounts payable, trade for fiscal 2012 was -$179.05K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2016-06-30 | -$64.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $188.04K 10-Q · filed 2016-08-11 | $220.55K derived: sum of 3 quarters · filed 2016-08-11 | $1.93M derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | $252.84K 10-Q · filed 2016-05-12 | $285.35K derived: sum of 2 quarters · filed 2016-05-12 | $2.00M derived: sum of 3 quarters · filed 2016-05-12 | $2.09M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-12-31 | $32.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $1.74M derived: sum of 2 quarters · filed 2016-03-24 | $1.84M derived: sum of 3 quarters · filed 2016-08-11 | $1.38M 10-K · filed 2016-03-24 |
| 2015-09-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.80M derived: sum of 2 quarters · filed 2016-08-11 | $1.34M 10-Q · filed 2015-11-12 | $1.29M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-06-30 | $92.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$367.10K 10-Q · filed 2016-08-11 | -$422.88K derived: sum of 3 quarters · filed 2016-08-11 | $670.85K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$459.60K 10-Q · filed 2016-05-12 | -$515.38K derived: sum of 2 quarters · filed 2016-05-12 | $578.34K derived: sum of 3 quarters · filed 2016-05-12 | $991.31K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$55.78K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $1.04M derived: sum of 2 quarters · filed 2016-03-24 | $1.45M derived: sum of 3 quarters · filed 2016-03-24 | $1.48M 10-K · filed 2016-03-24 |
| 2014-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.51M derived: sum of 2 quarters · filed 2015-11-12 | $1.54M 10-Q · filed 2015-11-12 | $1.84M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $412.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $445.31K 10-Q · filed 2015-08-12 | $751.01K derived: sum of 3 quarters · filed 2015-08-12 | $600.76K derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $32.34K 10-Q · filed 2015-05-14 | $338.04K derived: sum of 2 quarters · filed 2015-05-14 | $187.79K derived: sum of 3 quarters · filed 2015-05-14 | -$99.11K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $305.70K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $155.45K derived: sum of 2 quarters · filed 2015-03-25 | -$131.45K derived: sum of 3 quarters · filed 2015-03-25 | $395.79K 10-K · filed 2015-03-25 |
| 2013-09-30 | -$150.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$437.16K derived: sum of 2 quarters · filed 2014-11-10 | $90.08K 10-Q · filed 2014-11-10 | $190.86K derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | -$286.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $240.34K 10-Q · filed 2014-08-11 | $341.12K derived: sum of 3 quarters · filed 2014-08-11 | $145.27K derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $527.24K 10-Q · filed 2014-05-12 | $628.02K derived: sum of 2 quarters · filed 2014-05-12 | $432.17K derived: sum of 3 quarters · filed 2014-05-12 | $421.18K derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $100.78K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$95.07K derived: sum of 2 quarters · filed 2014-03-26 | -$106.05K derived: sum of 3 quarters · filed 2014-03-26 | -$179.05K 10-K · filed 2014-03-26 |
| 2012-09-30 | -$195.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$206.83K derived: sum of 2 quarters · filed 2013-11-12 | -$279.83K 10-Q · filed 2013-11-12 | -$348.22K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | -$10.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$83.99K 10-Q · filed 2013-08-12 | -$152.38K derived: sum of 3 quarters · filed 2013-08-12 | -$154.41K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | -$73.00K 10-Q · filed 2013-05-03 | -$141.39K derived: sum of 2 quarters · filed 2013-05-03 | -$143.42K derived: sum of 3 quarters · filed 2013-05-03 | -$187.74K derived: sum of 4 quarters · filed 2013-05-03 |
| 2011-12-31 | -$68.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$70.42K derived: sum of 2 quarters · filed 2013-02-26 | -$114.74K derived: sum of 3 quarters · filed 2013-02-26 | -$370.62K 10-K · filed 2013-02-26 |
| 2011-09-30 | -$2.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$46.35K derived: sum of 2 quarters · filed 2012-11-14 | -$302.23K 10-Q · filed 2012-11-14 | -$119.60K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | -$44.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | -$300.20K 10-Q · filed 2012-08-10 | -$117.56K derived: sum of 3 quarters · filed 2012-08-10 | -$394.83K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | -$255.88K 10-Q · filed 2012-05-14 | -$73.24K derived: sum of 2 quarters · filed 2012-05-14 | -$350.51K derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | $182.64K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | -$94.63K derived: sum of 2 quarters · filed 2012-03-27 | $829.32K 10-K · filed 2012-03-27 | |
| 2010-09-30 | -$277.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $646.68K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $923.95K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |